Tiziana Life Sciences Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | -100.0% | – | -100.0% | – | – | +3,247.4% | – | – | – | -82.0% | – | – | – | +70.2% | – | – | – | – | – | – | -18.6% | -189.1% | – | – | +0.0% | +207.3% | +0.0% | -51.6% | +44.3% | +0.0% | +65.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -234.1% | – | – | – | – | – | – | – | – | – | |
| – | +47.0% | -68.0% | +100.0% | +58.1% | -50.0% | +100.0% | -50.9% | +89.5% | -50.0% | +162.8% | +362.3% | -89.0% | +26.7% | +0.1% | – | – | +21.4% | -73.4% | – | – | – | +115.8% | – | – | – | +143.2% | – | – | -18.6% | -40.1% | +26.6% | +15.9% | +0.0% | +6.8% | +0.0% | -48.5% | +22.2% | +0.0% | +117.0% | – | |
| – | – | – | – | – | – | – | – | +2,403.8% | -95.8% | +112.4% | +427.0% | -19.8% | +65.1% | -30.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +305.0% | -54.0% | -2.4% | +83.0% | -53.8% | +100.0% | +22.5% | -11.9% | -54.9% | +162.8% | +1,018.2% | -90.5% | +95.3% | -2.5% | – | – | -15.0% | +11.6% | – | – | – | -16.6% | – | – | – | +147.4% | – | – | -18.6% | +18.0% | +26.6% | -58.5% | +0.0% | +106.1% | +0.0% | -28.4% | -2.9% | +0.0% | +37.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.0% | -66.7% | +100.0% | +0.0% | -50.0% | +72.8% | -35.7% | +98.5% | -52.4% | +132.6% | +547.6% | +2.5% | -82.3% | -0.1% | – | – | +134.5% | -92.6% | – | – | – | -92.2% | – | – | – | -100.0% | – | – | -18.6% | -28.6% | +26.6% | -21.0% | +0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -1,581.5% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.